A Sensitive New Test for Measuring Thymulin (A Thymic Peptide)

A new enzyme immunoassay detected thymulin at 5 pg/mL — more sensitive than existing tests and able to separately measure zinc-bound vs zinc-free forms.

Métreau, E et al.·Journal of immunological methods·1987·Preliminary Evidencein-vitro
RPEP-00056In VitroPreliminary Evidence1987RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
in-vitro
Evidence
Preliminary Evidence
Sample
Not reported

What This Study Found

The new enzyme immunoassay (EIA) for thymulin achieved a sensitivity of 32.5 ± 5 pg/mL (IC50) with a detection limit of 5 pg/mL. This was more sensitive than previously available radioimmunoassays.

The test was highly specific. It did not cross-react with thymosin alpha 1, thymopoietin II, or TP5 (another thymic peptide). Both the zinc-bound (biologically active) and zinc-free forms of thymulin showed the same immunoreactivity.

Mapping studies showed that the minimum peptide structure needed for detection was the C-terminal portion from lysine-3 to asparagine-9 (7 of the 9 amino acids).

Key Numbers

How They Did This

Classical competition immunoassay using thymulin conjugated to acetylcholinesterase as the tracer. Specific polyclonal rabbit anti-thymulin antibodies were used. Microtiter plates were coated with mouse monoclonal anti-rabbit IgG. Synthetic thymulin analogs were tested to map the epitope. Cross-reactivity with other thymic hormones was tested.

Why This Research Matters

Measuring thymulin in blood is one of the best ways to assess thymic function. This more sensitive test made it possible to track thymulin levels in diseases where thymic function declines, including aging, AIDS, and autoimmune conditions.

The Bigger Picture

Better measurement tools enable better research. This sensitive assay allowed researchers to track thymulin levels in disease states and aging, advancing understanding of thymic function.

What This Study Doesn't Tell Us

This is a methods paper, not a clinical study. The assay was validated with synthetic peptides and needs further validation in clinical samples. The polyclonal antibody approach means batch-to-batch variation is possible.

Questions This Raises

  • ?Can serum thymulin levels serve as a clinical biomarker for immune status?
  • ?Does zinc supplementation increase biologically active thymulin?

Trust & Context

Key Stat:
5 pg/mL detection limit More sensitive than previous radioimmunoassays for thymulin
Evidence Grade:
Preliminary — technical methodology paper establishing a new assay without clinical validation.
Study Age:
Published in 1987 — provided the measurement tool used in many subsequent thymulin studies.
Original Title:
An enzyme immunoassay for synthetic thymulin.
Published In:
Journal of immunological methods, 102(2), 233-42 (1987)
Database ID:
RPEP-00056

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Frequently Asked Questions

What is thymulin?

A 9-amino-acid peptide hormone produced by the thymus gland. It requires zinc to be biologically active and plays a role in T-cell development and immune regulation.

Why does zinc matter for thymulin?

Thymulin only becomes biologically active when bound to zinc. Without zinc, the peptide exists in an inactive form. This is why zinc deficiency can impair immune function through reduced thymulin activity.

Read More on RethinkPeptides

Cite This Study

RPEP-00056·https://rethinkpeptides.com/research/RPEP-00056

APA

Métreau, E; Pléau, J M; Dardenne, M; Bach, J F; Pradelles, P. (1987). An enzyme immunoassay for synthetic thymulin.. Journal of immunological methods, 102(2), 233-42.

MLA

Métreau, E, et al. "An enzyme immunoassay for synthetic thymulin.." Journal of immunological methods, 1987.

RethinkPeptides

RethinkPeptides Research Database. "An enzyme immunoassay for synthetic thymulin." RPEP-00056. Retrieved from https://rethinkpeptides.com/research/metreau-1987-an-enzyme-immunoassay-for

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.